sr 140333 has been researched along with Hypotension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonham, AC; Chen, CY; Munch, PA; Quail, AW | 1 |
| Bichon, D; Doutremepuich, JD; Ducoux, JP; Emonds-Alt, X; Heaulme, M; Neliat, G; Proietto, V; Santucci, V; Steinberg, R; Vilain, P | 1 |
2 other study(ies) available for sr 140333 and Hypotension
| Article | Year |
|---|---|
Postexercise hypotension in conscious SHR is attenuated by blockade of substance P receptors in NTS.
Topics: Animals; Blood Pressure; Consciousness; Hypertension; Hypotension; Male; Microinjections; Neurokinin-1 Receptor Antagonists; Physical Exertion; Piperidines; Quinuclidines; Rats; Rats, Inbred SHR; Solitary Nucleus | 2002 |
In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
Topics: Animals; Brain; Bronchoconstriction; Capillary Permeability; Cell Line; Dogs; Endothelium, Vascular; Guinea Pigs; Humans; Hypotension; Male; Muscle Relaxation; Muscle, Smooth; Neurokinin-1 Receptor Antagonists; Neurons; Piperidines; Quinuclidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tumor Cells, Cultured | 1993 |